- Home
- ARQT vs NAVN Comparison
ARQT vs NAVN Comparison
Compare ARQT & NAVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | NAVN |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.2B |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ARQT | NAVN |
|---|---|---|
| Price | $28.22 | $17.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $24.83 | ★ $25.50 |
| AVG Volume (30 Days) | 1.7M | ★ 2.6M |
| Earning Date | 02-24-2026 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $317,929,000.00 | ★ $656,339,000.00 |
| Revenue This Year | $85.51 | $29.39 |
| Revenue Next Year | $30.74 | $23.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.21 | 63.16 |
| 52 Week Low | $11.13 | $11.76 |
| 52 Week High | $31.77 | $22.75 |
Technical Indicators
Market Signals| Indicator | ARQT | NAVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | N/A |
| Support Level | $28.75 | N/A |
| Resistance Level | $30.60 | N/A |
| Average True Range (ATR) | 1.31 | 0.00 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 15.13 | 0.00 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About NAVN Navan Inc.
Navan Inc is an end-to-end, AI-powered software platform built to simplify the world-wide business T&E experience, benefiting users, customers, and suppliers. Its leveraged technology to reimagine business travel. The company deliver delightful, personalized experiences for users, efficiency and control for customers, and direct market access for suppliers-all powered by its proprietary AI framework, Navan Cognition. Geographically, the company operates in United States, United Kingdom and Other countries, of which United States derives maximum revenue.